Findings Do Not Support The Use Of Darbepoetin Alfa To Treat Anemic Heart Failure Patients

Researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients' health, nor does it reduce their risk of death from heart failure. Results of the international study were presented at the American College of Cardiology's annual meeting in San Francisco and published simultaneously online by The New England Journal of Medicine...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Blood / Hematology Source Type: news